Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

Published:2015-02-26 Issue:6 Volume:4 Page:871-886
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Saulnier Sholler Giselle L.¹²,Bond Jeffrey P.³,Bergendahl Genevieve¹,Dutta Akshita¹,Dragon Julie³,Neville Kathleen⁴,Ferguson William⁵,Roberts William⁶,Eslin Don⁷,Kraveka Jacqueline⁸,Kaplan Joel⁹,Mitchell Deanna¹,Parikh Nehal¹⁰,Merchant Melinda¹¹,Ashikaga Takamaru¹²,Hanna Gina⁷,Lescault Pamela Jean¹³,Siniard Ashley¹⁴,Corneveaux Jason¹⁴,Huentelman Matthew¹⁴,Trent Jeffrey¹⁴

Affiliation:

1. Helen DeVos Children's Hospital Grand Rapids Michigan

2. Michigan State University College of Medicine Grand Rapids Michigan

3. Department of Microbiology and Molecular Genetics University of Vermont College of Medicine Burlington Vermont

4. Children's Mercy Hospital Kansas City Missouri

5. Cardinal Glennon Children's Hospital St. Louis University St. Louis Missouri

6. UC San Diego School of Medicine and Rady Children's Hospital San Diego California

7. Arnold Palmer Hospital for Children Orlando Florida

8. Medical University of South Carolina Charleston South Carolina

9. Levine Children's Hospital Charlotte North Carolina

10. Connecticut Children's Medical Center Hartford Connecticut

11. NCI Center for Cancer Research Bethesda Maryland

12. Medical Biostatistics University of Vermont College of Medicine Burlington Vermont

13. Josephine Bay Paul Center for Comparative Molecular Biology and Evolution The Marine Biological Laboratory Woods Hole Massachusetts

14. Translational Genomics Research Institute Phoenix Arizona

Funder

Arms Wide Open Foundation

Beat NB

Because of Ezra Foundation

Brooke’s Blossoming Hope Foundation

Charles and Meryl Witmer Foundation

Daxton’s Fish

Dell Corporation

Ethan’s Rodeo

Ishan Gala Foundation

Lillie’s Friends Foundation

Max’s Ring of Fire

Melina’s White Light

Owen Moscone Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.436

Reference43 articles.

1. A population-based study of neuroblastoma incidence, survival, and mortality in North America.

2. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

3. Neuroblastoma: Biology, Prognosis, and Treatment

4. Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic analysis of the landscape of synthetic lethality-driven precision oncology;Med;2024-01

2. Arsenic Trioxide inhibits Activation of Hedgehog Pathway in Human Neuroblastoma Cell Line SK-N-BE(2) Independent of Itraconazole;Anti-Cancer Agents in Medicinal Chemistry;2023-12

3. Cancer Genomics and Evolution;Holland‐Frei Cancer Medicine;2022-10-21

4. A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma;Cancer Reports;2022-03-31

5. The landscape of receptor-mediated precision cancer combination therapy via a single-cell perspective;Nature Communications;2022-03-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3